People with schizophrenia do not show the normal benefits of social versus nonsocial attentional cues.
Journal
Neuropsychology
ISSN: 1931-1559
Titre abrégé: Neuropsychology
Pays: United States
ID NLM: 8904467
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
28
4
2020
medline:
15
1
2021
entrez:
28
4
2020
Statut:
ppublish
Résumé
Schizophrenia is associated with impairments in social motivation. Social attention has been proposed as an underlying mechanism for social motivation. However, studies in schizophrenia have rarely examined social attention, and none of these studies examined the effects with rapidly presented stimuli. The current study examined whether individuals with schizophrenia have reduced social attention and whether reduced social attention was related to social motivation deficits (measured with the Clinical Assessment Interview for Negative Symptoms) and decreased social functioning (Role Functioning Scale). Thirty-seven outpatients with schizophrenia and 29 healthy participants completed a gaze cueing task with directional social cues (eye gaze) and nonsocial cues (arrows) at varying stimulus onset asynchronies. As predicted, schizophrenia participants had reduced social attention relative to nonsocial attention, compared with healthy participants. Healthy participants were quicker to respond to social cues than nonsocial cues, but schizophrenia participants did not exhibit this same pattern. Schizophrenia participants showed higher accuracy when targets appeared in the same location as a directional cue (i.e., congruency) for nonsocial, but not social, cues. Contrary to expectations, reduced social attention was not significantly correlated with clinically rated social motivation deficits or decreased social functioning in the schizophrenia group. These findings provide evidence for social attention deficits in schizophrenia, but without a clear mapping of its influence on social motivation. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
Identifiants
pubmed: 32338943
pii: 2020-28781-001
doi: 10.1037/neu0000642
pmc: PMC8513804
mid: NIHMS1727684
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
620-628Subventions
Organisme : NIMH NIH HHS
ID : R21 MH102567
Pays : United States
Organisme : US Department of Veterans Affairs
Références
Neuropsychology. 2013 Sep;27(5):608-13
pubmed: 24040931
NPJ Digit Med. 2018 Apr 6;1:15
pubmed: 31304300
Schizophr Bull. 2018 Feb 15;44(2):242-249
pubmed: 28637195
Clin Neurophysiol. 2011 Mar;122(3):506-511
pubmed: 20702135
Neuron. 2008 May 8;58(3):306-24
pubmed: 18466742
Am J Psychiatry. 2013 Feb;170(2):165-72
pubmed: 23377637
Clin Psychol Rev. 2018 Jul;63:12-24
pubmed: 29870953
Community Ment Health J. 1993 Apr;29(2):119-31
pubmed: 8500285
Behav Brain Res. 2013 Jan 15;237:107-23
pubmed: 23000534
Schizophr Res. 2011 Mar;126(1-3):124-31
pubmed: 21159492
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2516-28
pubmed: 23928088
Schizophr Res. 2011 Nov;132(2-3):140-5
pubmed: 21798716
Transl Psychiatry. 2017 Mar 7;7(3):e1053
pubmed: 28267146
Front Hum Neurosci. 2014 Nov 10;8:912
pubmed: 25426057
Am J Psychiatry. 2008 Feb;165(2):214-20
pubmed: 18172018
Neuropsychologia. 2006;44(3):417-29
pubmed: 16045944
Soc Cogn Affect Neurosci. 2010 Dec;5(4):432-40
pubmed: 20304864
Front Psychol. 2013 Aug 16;4:527
pubmed: 23966966
Cogn Neuropsychiatry. 2017 Mar;22(2):122-136
pubmed: 28253092
Schizophr Bull. 2006 Apr;32(2):238-45
pubmed: 16254064
Schizophr Res. 2004 Dec 15;72(1):29-39
pubmed: 15531405
Neuroreport. 2003 Mar 3;14(3):489-93
pubmed: 12634510
Nat Rev Neurosci. 2002 Mar;3(3):201-15
pubmed: 11994752
Neuroimage. 2006 Oct 15;33(1):406-13
pubmed: 16949306
Psychopathology. 2008;41(2):77-84
pubmed: 18033976
Psychon Bull Rev. 2018 Dec;25(6):2005-2015
pubmed: 29435963
Trends Cogn Sci. 2012 Apr;16(4):231-9
pubmed: 22425667
J Exp Psychol Gen. 2004 Dec;133(4):516-33
pubmed: 15584804
Q J Exp Psychol (Hove). 2017 Aug;70(8):1549-1558
pubmed: 27207190
Cognition. 2008 Apr;107(1):330-42
pubmed: 17767926
Biol Psychiatry. 2008 Jul 1;64(1):34-9
pubmed: 18374901
Soc Cogn Affect Neurosci. 2015 Feb;10(2):294-301
pubmed: 24748545
Front Hum Neurosci. 2013 May 17;7:205
pubmed: 23730280
Neuropsychologia. 2009 Jan;47(2):370-81
pubmed: 18926835
Schizophr Res. 2011 Feb;125(2-3):161-8
pubmed: 21075600
J Exp Psychol Hum Percept Perform. 2018 Feb;44(2):206-214
pubmed: 28795836
Cognition. 2003 Feb;87(1):B1-10
pubmed: 12499107
J Cogn Neurosci. 2014 Jan;26(1):63-80
pubmed: 23937692
Trends Neurosci. 2016 Sep;39(9):587-596
pubmed: 27477199
Neuroscientist. 2014 Apr;20(2):150-9
pubmed: 23835449
Biol Psychiatry. 2004 Sep 1;56(5):301-7
pubmed: 15336511
Q J Exp Psychol. 1980 Feb;32(1):3-25
pubmed: 7367577
Neuropsychology. 2011 Jan;25(1):76-85
pubmed: 20919764
Front Psychol. 2019 Mar 15;10:560
pubmed: 30930822
Schizophr Bull. 1998;24(3):413-24
pubmed: 9718633
Neuropsychopharmacology. 2016 Jun;41(7):1691-6
pubmed: 26818126
Trends Cogn Sci. 2016 Apr;20(4):260-281
pubmed: 26952739
Trends Cogn Sci. 2009 Mar;13(3):135-43
pubmed: 19223221
Am J Psychiatry. 2005 Mar;162(3):495-506
pubmed: 15741466
Psychophysiology. 2004 Sep;41(5):716-28
pubmed: 15318878
Psychiatry Res. 2008 Apr 15;158(3):287-96
pubmed: 18262285
J Cogn Neurosci. 2004 Oct;16(8):1320-6
pubmed: 15509381
Psychol Bull. 2007 Jul;133(4):694-724
pubmed: 17592962
Schizophr Bull. 2019 Sep 11;45(5):991-1000
pubmed: 31317191